Contributor Page
Torys LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 865 0040
Fax: +1 416 865 7380
79 Wellington St. W.
Box 270, TD South Tower
M5K 1N2
By Dennis Mahony, Michael Fortier, Tyson Dyck, Henry Ren
Ontario's Ministry of the Environment, Conservation and Parks (MECP) released Preserving and Protecting our Environment for Future Generations: A Made-in-Ontario Environment Plan (Plan) on November 29
By Gillian Dingle, John Fabello
Regulators continue to focus on real and perceived conflicts of interest, whether as between individual advisers and their clients, or as between registered portfolio managers and affiliates.
By Blair Keefe, David Seville, Eli Monas
Canada's bank recapitalization (bail-in) regime came into effect on September 23.
By Andrew Gray, Rebecca Wise, Evan Dickinson
The Alberta Securities Commission (ASC) introduced a Whistleblower Program on November 20, which enables whistleblowers to report securities-related misconduct to the ASC without fear of repercussion
By Michelle Nelles, Kevin Tuohy
Nearly five years after receiving royal assent, amendments to the Trademarks Act will come into force on June 17, 2019.
By Alex Tanenbaum
Seller representations are often the most carefully negotiated provisions in a real estate purchase and sale agreement.
By Molly Reynolds
The year isn't over yet – but the trend is clear. With new security flaws being discovered in software every day – on top of plain old human negligence and nosiness – our data are at more risk than ever.
By Christopher Caparelli
The United States fully re-imposed sanctions against Iran on November 5 that had been lifted in January 2016 as part of the global deal to curtail Iran's development of nuclear weapons.
By Dany Assaf
The International Monetary Fund recently cut its global growth forecasts, citing concerns about further disruptions in trade policies.
By Eileen McMahon, Yolande Dufresne, Yu Seon Gadsden-Chung
Medical devices in Canada are regulated federally by Health Canada's Medical Devices Bureau of the Therapeutic Products Directorate and governed by Canada's Food and Drugs Act (Act) and Medical Device Regulations (Regulations).
By Blair Keefe, Peter Aziz, Eli Monas
Bill C-86, Budget Implementation Act, 2018, No. 2 (Bill), was introduced in the House of Commons on October 29.
By Edward Fan, Steve Hundal
The Commissioner of Patents of the Canadian Intellectual Property Office (CIPO) has released its decision in CD 1457 (Decision).
By Lisa Talbot, Thomas Stevenson, Pat Denroche
On October 23, the provincial government tabled the Making Ontario Open for Business Act (Bill 47).
By Christopher Caparelli
As a part of the Foreign Investment Risk Review Modernization Act (FIRRMA),1 the Committee on Foreign Investment in the United States (CFIUS) will begin its first pilot program ...
By Stephanie Stimpson, John Emanoilidis, Michael Pedlow, Andrew Cooley
Increases in U.S. production coupled with increased costs and regulatory uncertainty in Canada have contributed to a general investment decline in Canada's oil and gas sector since the highs of 2014.
Contributor's Topics